- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03004690
Testing of Personal Protective Equipment (PPE) (PPE-Test)
Limiting Factors for Wearing Personal Protective Equipment (PPE) in a Health Care Environment Evaluated in a Randomised Study: Source of Errors?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this randomized study following good clinical practice guidelines nineteen study volunteers were recruited to wear one of two different types of randomly allocated PPE suits (www.randomizer.at) and to perform four different tests six times at 22°C on one day and four times at 28°C on another day in the local core facility clinical research center.
Study participants Recruiting was based on voluntary registration in response to a public announcement. The study was subjected to the local ethical committee review (No. 23-321 ex 10/11) and all persons gave written informed consent according to the Helsinki Declaration. Key lifestyle and medical parameters were documented for every subject. Exclusion criteria were pregnancy, latex and polyvinyl chloride allergy, claustrophobia, hypotension, history of vein thrombosis, chronic obstructive pulmonary disease, epilepsy, cardiovascular and pulmonary diseases, and infectious diseases. Ten male and nine female volunteers were recruited, aged between 21 and 38 years with body-mass-indices from 17.2 to 32.5.
PPE suits Suit A: TychemR F overall whole-body (DuPont de Nemours and Company, 3M, Austria) suit including socks with a reusable light hood VersafloTM S-655 (3M, Austria) and an external 3M JupiterTM Powered Air Turbo Unit (3M Austria) providing head-only positive pressure.
Suit B: 3MTM JS-series Typ 3 Chemical and Respiratory Protective Suit (CRPS, 3M, Austria) with integrated respirator 3M Jupiter JP-ER-03 Powered Air Purifying Turbo (3M, Austria) fixed as a rucksack generating whole-suit positive pressure.
With both suits, Sempercare surgical gloves (Sempermed, powder-free 150; Semperit, Austria) as the first layer, Ansell Sol-Vex gloves 37-900 (Ansell, Medical GBU, VWR, Austria) as a second layer and white rubber boots were worn. Gloves and boots were sealed to the suit using adhesive tape. Tests I and II were performed in a mock-up glove box providing a third layer of latex gloves.
Tests Four tests were repeatedly performed as well as an additional questionnaire on comfort and general condition before the tests started and after every four-test-series. Test I comprised correct assembly and position of coloured and numbered 2 mL tubes and screwcaps in a storage device to test fine motor skills, concentration and error rate. Test II checked the same skills in a different approach by pipetting different volumes of coloured water into a 96-well microliter plate according to a given pattern. Test III "d2 Test of Attention" is a timed test of selective attention and a standardized refinement of a visual cancellation. In response to the discrimination of similar visual stimuli, the test measures processing speed, rule compliance, and quality of performance, allowing estimation of individual attention and concentration performance. Test IV investigated reaction time, mobility, speed and physical exercise by tapping touch sensors directed by signs on a screen (tapping test by talent-systems sportconsulting Gmbh, www.werthner.at). All subjects performed the tests after randomisation (www.randomizer.at) of the starting exercise. For example, subject one started with test I while subject two started with test II at the same time. After ten minutes testing time and a five minute break, subject one carried on with test II and subject two with test I. After a five minute break, subject one started with test III while subject two performed test IV over a 10 minute period. Again after five minutes break, subject one continued with test IV and subject two with test III. Subjects documented their individual comfort and general condition in a structured questionnaire before the tests started and after every series of tests. All four tests were repeated 6 times at 22°C (6 hours total working time) on the first test day and four times at 28°C (4 hours total working time) on the second test day. Limiting factors for working conditions were ranked after every series from 1 to 10 on the questionnaire whereby ranking 10 was a reason for terminating the study. Heart rate (HR) was measured with a wireless heart rate monitor placed below the sternum directly on the skin (Garmin Forerunner 305) before and after the test series (data used for statistical analysis) and additionally recorded during the test series. Body temperature and body weight were measured as well as weight of the respective PPE for calculating dehydration and evaluation of heat stress.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Graz, Austria, 8036
- Medical University Graz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy, good physical and mental resiliance
Exclusion Criteria:
- pregnancy, latex and PVC allergy, claustrophobia, hypotension, vein thrombosis, COPD, epilepsy, cardiovascular and pulmonary diseases, and infectious diseases.
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Performance temperature 22°C
Participants wearing PPE suit A or PPE suit B perform tests I -IV at 22°C.
|
In this randomized study following good clinical practice guidelines nineteen study volunteers were recruited to wear one of two different types of randomly allocated PPE suits.
Suit A has to be used by randomly selected participants to perform four different tests six times at 22°C on one day and four times at 28°C on another day in the local core facility clinical research center.
Other Names:
Suit B has to be used by randomly selected participants to perform four different tests six times at 22°C on one day and four times at 28°C on another day in the local core facility clinical research center.
Other Names:
|
EXPERIMENTAL: Performance temperature 28°C
Participants wearing PPE suit A or PPE suit B perform tests I -IV at 28°C.
|
In this randomized study following good clinical practice guidelines nineteen study volunteers were recruited to wear one of two different types of randomly allocated PPE suits.
Suit A has to be used by randomly selected participants to perform four different tests six times at 22°C on one day and four times at 28°C on another day in the local core facility clinical research center.
Other Names:
Suit B has to be used by randomly selected participants to perform four different tests six times at 22°C on one day and four times at 28°C on another day in the local core facility clinical research center.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical measurements: Heart rate at 22°C and 28°C in each suit with 19 participants
Time Frame: up to 2 months
|
up to 2 months
|
|
Measurement of concentration (d2 Test) at 22°C and 28°C in each suit with 19 participants.
Time Frame: up to 2 months
|
This test will be analysed by descriptive analysis.
|
up to 2 months
|
Measurement of error rates at 22°C and 28°C in each suit with 19 participants
Time Frame: up to 2 months
|
For both temperatures repeated measurements and analysis of variances (rmANOVA) to assess effects of working time as a within subject factor and suit (A, B) as a between subject factor on the amount of processed tubes and the amount of wrongly screwed or arranged tubes are performed.
|
up to 2 months
|
Measurement of individual perception and wellbeing during all test series by individual questionnaires at 22°C and 28°C in each suit with 19 participants.
Time Frame: up to 2 months
|
Questionnaire data are recorded 7 times at 22°C and 5 times at 28°C and analysed with descriptive statistics.
|
up to 2 months
|
Physical measurements: Fluid loss at 22°C and 28°C in each suit with 19 participants.
Time Frame: up to 2 months
|
up to 2 months
|
|
Physical measurements: Body temperature at 22°C and 28°C in each suit with 19 participants.
Time Frame: up to 2 months
|
up to 2 months
|
|
Measurement of reaction time at 22°C and 28°C in each suit with 19 participants.
Time Frame: upt o 2 months
|
This test will be analysed by descriptive analysis.
|
upt o 2 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kurt Zatloukal, Prof., kurt.zatloukal@medunigraz.at
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-321
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Personal Protective Equipment
-
Virginia Commonwealth UniversityCompletedPersonal Protective EquipmentUnited States
-
University of Campinas, BrazilNot yet recruitingPersonal Protective Equipment
-
Kezban Aydan OkuyucuCompletedAirway Management | Personal Protective EquipmentTurkey
-
Hospital Italiano de Buenos AiresCompletedPersonal Protective Equipment | Self ContaminationArgentina
-
Brigham and Women's HospitalMemorial Sloan Kettering Cancer Center; Massachusetts General HospitalRecruitingPersonal Protective EquipmentUnited States
-
Bangkok Metropolitan Administration Medical College...Completed
-
Hospital de Clinicas José de San MartínClaudio Yaryour; Fermepin Marcelo; Luis Sarotto; Federico Rodriguez Cairoli; Angela... and other collaboratorsUnknownVirus Diseases | SARS-CoV 2 | COVID | Health Personnel Attitude | rt PCR | Personal Protective Equipment PPE
-
University of VictoriaRecruitingInflammatory Response | Heat Stress, Exertional | Firefighter Personal Protective EquipmentCanada
-
University of the Balearic IslandsCompletedCovid19 | Personal Protective EquipmentSpain
-
University of OxfordCompletedCovid19 | Personal Protective EquipmentUnited Kingdom
Clinical Trials on PPE Suit A
-
Hospital Italiano de Buenos AiresCompletedPersonal Protective Equipment | Self ContaminationArgentina
-
ReWalk Robotics, Inc.Completed
-
ReWalk Robotics, Inc.CompletedParaplegia | Spinal Cord Injuries (SCI)United States, Italy
-
Institute of Mountain Emergency MedicineCompletedCardiopulmonary Resuscitation | Personal Protective EquipmentItaly
-
University of OxfordCompletedCovid19 | Personal Protective EquipmentUnited Kingdom
-
University of ExtremaduraCompleted
-
Ariel UniversityTel Hai CollegeNot yet recruiting
-
University Health Network, TorontoUnknown
-
Indonesia UniversityRecruiting
-
Exoneural Network ABHannover Medical School; Ottobock SE & Co. KGaA; Pohlig GmbHRecruitingCerebral Palsy | Hemiplegia | Tetraplegia | Pain Syndrome | Spasticity | Balance | Muscle | DiplegiaGermany